Also, Esculetin, dihydroxy coumarin, showed in different studies on Imiquimod (IMQ)-induced psoriasis in mouse models, has a magical power to suppress NF-κB activation, PASI scores, and improved skin immunopathology (Chen et al. 2018). Here, NFKB1 is linked to psoriasis.